Radiopharm Theranostics (RADX) Receivables - Net (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Receivables - Net for 2 consecutive years, with $10.4 million as the latest value for Q2 2025.

• On a quarterly basis, Receivables - Net rose 953.26% to $10.4 million in Q2 2025 year-over-year; TTM through Jun 2025 was $10.4 million, a 953.26% increase, with the full-year FY2025 number at $10.4 million, up 953.26% from a year prior.
• Receivables - Net was $10.4 million for Q2 2025 at Radiopharm Theranostics, up from $987413.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $10.4 million in Q2 2025 to a low of $987413.0 in Q2 2024.

Peer Comparison